In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

The law that created ASTP as a formal federal agency gave it duties such as supporting a more effective marketplace and greater competition. Stephen Konya, ASTP’s chief, innovation and strategic ...

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference.

Clinicians continue to struggle with excessive administrative burden and fragmented technologies. Their desktops are crowded with dozens of apps, but they still somehow can’t locate the data ...

President Trump’s latest strategy to tackle high drug prices aims to tie the price of U.S. prescription medicines to the prices paid for the same products in other countries, a so-called “most ...

BioMarin Pharmaceutical is building up its pipeline with the acquisition of Inozyme Pharma in a $270 million deal centered on an enzyme replacement therapy that could become the first FDA-approved ...

Data and system integration is less glamorous compared to the latest conversations on how AI can improve healthcare delivery and outcomes. However, for AI or other technologies to be successful, a ...